DelveInsight’s Degenerative Disc Disease market report thoroughly explains the Degenerative Disc Disease historical and forecasted epidemiology and the Degenerative Disc Disease market trends in the 7MM.
Some of the Key Highlights from the Degenerative Disc Disease Market Report
-
According to Bruin et al. (2018), degenerative changes were discovered in 456/648 patients (70.4%).
-
According to data published on the International Society for Pediatric Neurosurgery (ISPN), DDD is more common than previously thought, with 26% of asymptomatic children 16 years old demonstrating disc degeneration on MRI.
-
The leading players in the Degenerative Disc Disease market include Mesoblast, Gruenthal, Stayble Therapeutics, DiscGenics, Kuros Biosciences, Ankasa Therapeutics, Biorestorative Therapies, AnGes, and others.
-
Key Degenerative Disc Disease therapies in the pipeline include Rexlemestrocel, STA363, IDCT, Fibrin-PTH (KUR-113), ART352-L, BRTX-100, AMG0103, and others.
-
Rexlemestrocel, also known as Rexlemestrocel-L or MPC-06-ID, is a lead product candidate in late-stage development by Mesoblast in collaboration with Gruenthal to treat chronic low back pain caused by disc degeneration (CLBP).
-
Fibrin-PTH (KUR-113) is Kuros Biosciences’ first investigational drug-biologic product candidate for spinal fusion.
Request for a sample to know more @ Degenerative Disc Disease Market Outlook
Degenerative Disc Disease: Overview
Degenerative Disc Disease is a common disorder characterised by progressive degeneration of the intervertebral discs, which causes them to become deformed and mechanically dysfunctional. It is a catch-all term for various structural changes in the spine, including disc height loss, disc bulges, hydration, and nerve impingement in the spine, among others.
Degenerative Disc Disease Epidemiology Segmentation
The Degenerative Disc Disease report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:
-
Chronic Low Back Pain Total Prevalent Cases
-
Degenerative Disc Disease Total Prevalent Cases
-
Degenerative Disc Disease Diagnosed Cases
-
Degenerative Disc Disease Age-Specific and Gender-Specific Cases
-
Degenerative Disc Disease Severity-Specific Cases
-
Degenerative Disc Disease Treated Cases
Degenerative Disc Disease Treatment Landscape
Degenerative Disc Disease treatments are either passive or active. To help control the DDD symptoms, a combination of treatments is usually used. Passive Degenerative Disc Disease treatments are rarely effective on their own; almost always, an active component, such as exercise, is required. Passive Degenerative Disc Disease treatments for low back pain caused by degenerative disc disease may include pain medication, epidural injections, artificial disc replacement, diskectomy, and spinal fusion.
Degenerative Disc Disease Market Outlook
The anticipated entry of novel therapies such as IDCT, Rexlemestrocel, and others will fuel the Degenerative Disc Disease market growth during the forecast period (2021-30), and advances in cell biology will also contribute to the development of novel therapeutics for Degenerative Disc Disease.
Get a detailed analysis of the market @ Degenerative Disc Disease Market Share
Degenerative Disc Disease Pipeline Therapies and Key Companies
-
Rexlemestrocel: Mesoblast/ Gruenthal
-
STA363: Stayble Therapeutics
-
IDCT: DiscGenics
-
Fibrin-PTH (KUR-113): Kuros Biosciences
-
ART352-L: Ankasa Therapeutics
-
BRTX-100: Biorestorative Therapies
-
AMG0103: AnGes
Table of Contents
|
1. |
Key Insights |
|
2. |
Executive Summary of Degenerative Disk Disease (DDD) |
|
3. |
SWOT Analysis of Degenerative Disk Disease (DDD) |
|
4. |
Degenerative Disk Disease (DDD): Market Share (%) Distribution Overview at a Glance: By Country |
|
5. |
Degenerative Disk Disease Epidemiology and Market Methodology |
|
6. |
Degenerative Disk Disease (DDD): Disease Background and Overview |
|
7. |
Degenerative Disk Disease Epidemiology and Patient Population |
|
8. |
Degenerative Disk Disease Epidemiology Scenario: 7MM |
|
9. |
Degenerative Disk Disease The United States Epidemiology |
|
10. |
Degenerative Disk Disease EU-5 Epidemiology |
|
11. |
Degenerative Disk Disease Japan Epidemiology |
|
12. |
Degenerative Disk Disease Current Treatment Practices |
|
13. |
Degenerative Disk Disease Unmet Needs |
|
14. |
Patient Journey of Degenerative Disk Disease (DDD) |
|
15. |
Key Endpoints in Degenerative Disk Disease (DDD) Clinical Trials |
|
16. |
Degenerative Disk Disease Marketed Therapies |
|
17. |
Degenerative Disk Disease Emerging Therapies |
|
18. |
Conjoint Analysis of Degenerative Disk Disease (DDD) |
|
19. |
Degenerative Disk Disease (DDD): Eight Major Market Analysis |
|
20. |
Degenerative Disk Disease 7MM Market Size |
|
21. |
Degenerative Disk Disease The United States Market Size |
|
22. |
Degenerative Disk Disease EU-5 Market Size |
|
23. |
Degenerative Disk Disease Japan Market Size |
|
24. |
Market Access and Reimbursement of Degenerative Disk Disease (DDD) Therapies |
|
25. |
Degenerative Disk Disease Market Drivers |
|
26. |
Degenerative Disk Disease Market Barriers |
|
27. |
Appendix |
|
28. |
DelveInsight Capabilities |
|
29. |
Disclaimer |
|
30. |
About DelveInsight |
Get in touch with our business executive for Healthcare Due Diligence Services
Related Reports
DelveInsight’s “Lumbar Disc Disease- Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Lumbar Disc Disease, historical and forecasted epidemiology as well as the Lumbar Disc Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sandeep Joshi
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/